Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS

OBJECTIVE: To assess the impact of laquinimod treatment on monocytes and to investigate the underlying immunomodulatory mechanisms in MS. METHODS: In this cross-sectional study, we performed in vivo and in vitro analyses of cluster of differentiation (CD14(+)) monocytes isolated from healthy donors...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Sinah, Jolivel, Valérie, Kraus, Stefan H.-P., Zayoud, Morad, Rosenfeld, Karolina, Tumani, Hayrettin, Furlan, Roberto, Kurschus, Florian C., Waisman, Ari, Luessi, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676421/
https://www.ncbi.nlm.nih.gov/pubmed/33203651
http://dx.doi.org/10.1212/NXI.0000000000000908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676421/
https://www.ncbi.nlm.nih.gov/pubmed/33203651
http://dx.doi.org/10.1212/NXI.0000000000000908

Ejemplares similares